CIK 0000310158
- Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221918501
- Phone
- +1 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,611,875
- in 1 filing
Net −$8,611,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-04 | Zachary Jennifer EVP, General Counsel | Shares withheld for taxes | −2,843 | $77.67 | $221K | 6,646.5 |
| 2020-05-04 | Zachary Jennifer EVP, General Counsel | Exercise or conversion · Restricted Stock Unit | −5,772 | 5,772 | ||
| 2020-05-03 | Karachun Rita A Sr. VP Fince-Global Controller | Exercise or conversion | +875 | $77.67 | $68K | 25,933.97 |
| 2020-05-03 | Karachun Rita A Sr. VP Fince-Global Controller | Shares withheld for taxes | −431 | $77.67 | $33K | 25,502.97 |
| 2020-05-03 | Karachun Rita A Sr. VP Fince-Global Controller | Exercise or conversion · Restricted Stock Unit | −875 | 1,750 | ||
| 2020-05-03 | Fleming Michael SVP Chief Ethics & Com Officer | Exercise or conversion | +1,541 | $77.67 | $120K | 6,089.33 |
| 2020-05-03 | Fleming Michael SVP Chief Ethics & Com Officer | Shares withheld for taxes | −529 | $77.67 | $41K | 5,560.33 |
| 2020-05-03 | Fleming Michael SVP Chief Ethics & Com Officer | Exercise or conversion · Restricted Stock Unit | −1,541 | 3,084 | ||
| 2020-05-01 | Zachary Jennifer EVP, General Counsel | Grant or award · Stock Option (Right to Buy) | +75,514 | 75,514 | ||
| 2020-05-01 | PERLMUTTER ROGER M Exe V-P & Pres, MRL | Grant or award · Stock Option (Right to Buy) | +151,029 | 151,029 | ||
| 2020-05-01 | Nally Michael EVP, Chief Marketing Officer | Grant or award · Stock Option (Right to Buy) | +57,391 | 57,391 | ||
| 2020-05-01 | MIZELL STEVEN EVP, Chief HR Officer | Grant or award · Stock Option (Right to Buy) | +57,391 | 57,391 | ||
| 2020-05-01 | Karachun Rita A Sr. VP Fince-Global Controller | Grant or award · Stock Option (Right to Buy) | +21,144 | 21,144 | ||
| 2020-05-01 | Karachun Rita A Sr. VP Fince-Global Controller | Grant or award · Restricted Stock Unit | +2,704 | 2,704 | ||
| 2020-05-01 | Gerberding Julie L. EVP Strat Comm, GI Pub Policy | Grant or award · Stock Option (Right to Buy) | +33,226 | 33,226 | ||
| 2020-05-01 | FRAZIER KENNETH C Chairman, President & CEO | Grant or award · Stock Option (Right to Buy) | +475,740 | 475,740 | ||
| 2020-05-01 | Fleming Michael SVP Chief Ethics & Com Officer | Grant or award · Stock Option (Right to Buy) | +21,144 | 21,144 | ||
| 2020-05-01 | Fleming Michael SVP Chief Ethics & Com Officer | Grant or award · Restricted Stock Unit | +2,704 | 2,704 | ||
| 2020-05-01 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Grant or award · Stock Option (Right to Buy) | +75,514 | 75,514 | ||
| 2020-05-01 | Davis Robert M EVP, Global Svcs & CFO | Grant or award · Stock Option (Right to Buy) | +120,823 | 120,823 |
Page 51 of 52 · 1,021 trades